These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25017180)

  • 1. Effect of (-)-epigallocatechin gallate on the fibrillation of human serum albumin.
    Bhattacharya S; Pandey NK; Roy A; Dasgupta S
    Int J Biol Macromol; 2014 Sep; 70():312-9. PubMed ID: 25017180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the altered binding mode of green tea polyphenols with human serum albumin on complexation with copper.
    Singha Roy A; Ghosh KS; Dasgupta S
    J Biomol Struct Dyn; 2013 Oct; 31(10):1191-206. PubMed ID: 23145958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin stabilizes (-)-epigallocatechin gallate in human serum: binding capacity and antioxidant property.
    Bae MJ; Ishii T; Minoda K; Kawada Y; Ichikawa T; Mori T; Kamihira M; Nakayama T
    Mol Nutr Food Res; 2009 Jun; 53(6):709-15. PubMed ID: 19437485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of (-)-epigallocatechin-3-gallate with human serum albumin: fluorescence, fourier transform infrared, circular dichroism, and docking studies.
    Maiti TK; Ghosh KS; Dasgupta S
    Proteins; 2006 Aug; 64(2):355-62. PubMed ID: 16705651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the galloyl moiety in tea catechins on binding affinity for human serum albumin.
    Minoda K; Ichikawa T; Katsumata T; Onobori K; Mori T; Suzuki Y; Ishii T; Nakayama T
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(5):331-4. PubMed ID: 21228505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization.
    Ishii T; Ichikawa T; Minoda K; Kusaka K; Ito S; Suzuki Y; Akagawa M; Mochizuki K; Goda T; Nakayama T
    Biosci Biotechnol Biochem; 2011; 75(1):100-6. PubMed ID: 21228463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of polyphenols with proteins: binding of (-)-epigallocatechin gallate to serum albumin, estimated by induced circular dichroism.
    Nozaki A; Hori M; Kimura T; Ito H; Hatano T
    Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):224-8. PubMed ID: 19182419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution at the C-3 Position of Catechins Has an Influence on the Binding Affinities against Serum Albumin.
    Ikeda M; Ueda-Wakagi M; Hayashibara K; Kitano R; Kawase M; Kaihatsu K; Kato N; Suhara Y; Osakabe N; Ashida H
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28218710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of (-)-epigallocatechin-3-gallate on glucose-induced human serum albumin glycation.
    Li M; Hagerman AE
    Free Radic Res; 2015; 49(8):946-53. PubMed ID: 25794449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
    Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of (-)-epigallocatechin gallate with lysozyme-conjugated silver nanoparticles.
    Chandra GK; Tripathy DR; Dasgupta S; Roy A
    Appl Spectrosc; 2012 Jul; 66(7):744-9. PubMed ID: 22710368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of (-)-epicatechin-3-gallate and (-)-epigallocatechin-3-gallate on the binding of tegafur to human serum albumin as determined by spectroscopy, isothermal titration calorimetry, and molecular docking.
    Yuan L; Liu M; Shi Y; Yan H; Han J; Liu L
    J Biomol Struct Dyn; 2019 Jul; 37(11):2776-2788. PubMed ID: 30101645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinopeptide formation associated with the disruptive effect of epigallocatechin-gallate on lysozyme fibrils.
    Cao N; Zhang YJ; Feng S; Zeng CM
    Int J Biol Macromol; 2015; 78():389-95. PubMed ID: 25931397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation and Aggregation of Human Serum Albumin in the Presence of Green Tea Polyphenol (EGCg) and/or Palmitic Acid.
    Sun X; Ferguson HN; Hagerman AE
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Serum Albumin Increases the Stability of Green Tea Catechins in Aqueous Physiological Conditions.
    Zinellu A; Sotgia S; Scanu B; Forteschi M; Giordo R; Cossu A; Posadino AM; Carru C; Pintus G
    PLoS One; 2015; 10(7):e0134690. PubMed ID: 26230943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit.
    Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP
    Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of green tea polyphenols in the inhibition of collagenolytic activity by collagenase.
    Madhan B; Krishnamoorthy G; Rao JR; Nair BU
    Int J Biol Macromol; 2007 Jun; 41(1):16-22. PubMed ID: 17207851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.
    Van Aller GS; Carson JD; Tang W; Peng H; Zhao L; Copeland RA; Tummino PJ; Luo L
    Biochem Biophys Res Commun; 2011 Mar; 406(2):194-9. PubMed ID: 21300025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.